from Reuters: Business News https://reut.rs/2KIfeKM
Tuesday, April 16, 2019
J&J beats estimates on pharma strength, raises sales forecast
Johnson & Johnson beat quarterly profit estimates on Tuesday and raised its adjusted sales growth forecast for the year, driven by demand for its treatment for psoriasis and Crohn's disease and cancer drugs Darzalex and Imbruvica.
from Reuters: Business News https://reut.rs/2KIfeKM
from Reuters: Business News https://reut.rs/2KIfeKM
Related Posts:
Wells Fargo hit with lawsuit over robocalls to wrong numbers- U.S. economic growth slows slightly in third quarter; outlook less upbeat
- Exclusive: Airbus to name outsider after board hastened CFO's exit - sources
- Britain's SFO denied permission to charge Barclays over 2008 fundraising
- Soothing words from Fed as rate hits ceiling for first time
0 comments:
Post a Comment